ArticleACS omega2024
A Miniaturized Method for Evaluating the Dynamic Gas-Phase Adsorption and Degradation of Sarin on Porous Adsorbents at Different Humidity Levels.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal organic frameworks based on zirconium nodes (Zr-MOFs) have impressive adsorption capacities, and many can rapidly hydrolyze toxic organophosphorus nerve agents. They could thus potentially replace commonly used adsorbents in respiratory filters. However, current test methodologies are poorly adapted to screen the large number of available MOFs, and data for nerve agent adsorption by MOFs are scarce. This paper presents a miniaturized method for assessing the capacity of Zr-MOFs for dynamic gas phase adsorption and degradation of sarin (GB) into the primary hydrolysis product isopropyl methyl phosphonic acid (IMPA). The method was validated by comparing the dynamic adsorption capacities of activated carbon (AC) and NU-1000 for GB under dry and humid conditions. Under dry conditions, unimpregnated AC had a greater capacity for GB uptake (0.68 ± 0.06 g/g) than pelletized NU-1000 (0.36 ± 0.03 g/g). At 55% relative humidity (RH), the capacity of AC was largely unchanged (0.72 ± 0.10 g/g) but that of NU-1000 increased slightly, to 0.46 ± 0.10 g/g. However, NU-1000 exhibited poor water retention at 55% RH. For both adsorbents, the degree of hydrolysis of GB into IMPA was significantly greater at 55% RH than under dry conditions, but the overall degree of hydrolysis was limited in both cases. Further tests at higher relative humidities are needed to fully evaluate the ability of NU-1000 to degrade GB after adsorption from the gas phase. The proposed experimental setup uses very small amounts of both adsorbent material (20 mg) and toxic agent, making it ideal for assessing new MOFs. However, future methodological challenges are reliable generation of sarin at higher RH and exploring sensitive methods to monitor degradation products from nerve agents in real-time.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.